Characterization of viable but nonculturable state of .

Syeda Umme Habiba Wahid, Bronwyn E Campbell, Robert J Moore, Taghrid Istivan
Author Information
  1. Syeda Umme Habiba Wahid: School of Science, RMIT University, Bundoora, Victoria, Australia.
  2. Bronwyn E Campbell: School of Science, RMIT University, Bundoora, Victoria, Australia.
  3. Robert J Moore: School of Science, RMIT University, Bundoora, Victoria, Australia. ORCID
  4. Taghrid Istivan: School of Science, RMIT University, Bundoora, Victoria, Australia. ORCID

Abstract

is an opportunistic bacterial pathogen linked with a range of human diseases. The objective of this study was to investigate the viable but nonculturable (VBNC) state of the bacterium. To induce the VBNC state, cells were maintained in sterilized phosphate-buffered saline at 4��C for three weeks. The VBNC cells were monitored using quantitative analysis by propidium monoazide (PMAxx) coupled with quantitative real-time PCR (PMAxx-qPCR), targeting the subunit B gene. The results demonstrated that ATCC 51562 entered the VBNC state in 15 days, while ATCC 51561 entered the VBNC state in 9 days. The viable cell counts, assessed by PMAxx-qPCR, consistently remained close to the initial level of 10 CFU���ml, indicating a substantial portion of the cell population had entered the VBNC state. Notably, morphological analysis revealed that the VBNC cells became coccoid and significantly smaller. The cells could be resuscitated through a temperature increase in the presence of a highly nutritious growth medium. In conclusion, under environmental stress, most cells converted to the VBNC state. The VBNC state of may be important for its environmental survival and spread, and the presence of VBNC forms should be considered in environmental and clinical monitoring.

Keywords

Associated Data

Dryad | 10.5061/dryad.0cfxpnw8v

References

  1. Sci Rep. 2018 Jan 30;8(1):1902 [PMID: 29382867]
  2. Microb Ecol. 1982 Dec;8(4):313-23 [PMID: 24226049]
  3. J Clin Microbiol. 1989 Aug;27(8):1775-81 [PMID: 2768465]
  4. Int J Food Microbiol. 2020 Apr 2;318:108467 [PMID: 31835094]
  5. Gut Pathog. 2016 Jun 01;8:27 [PMID: 27252786]
  6. Front Cell Infect Microbiol. 2012 Feb 03;2:4 [PMID: 22919596]
  7. J Bacteriol. 2019 Jan 11;201(3): [PMID: 30420452]
  8. Int J Food Microbiol. 2011 Nov 1;150(2-3):171-7 [PMID: 21855156]
  9. Lett Appl Microbiol. 2008 Mar;46(3):377-82 [PMID: 18266640]
  10. Sci Rep. 2020 Feb 6;10(1):1957 [PMID: 32029755]
  11. Arch Microbiol. 2007 Sep;188(3):283-8 [PMID: 17492270]
  12. Curr Opin Gastroenterol. 2017 Jan;33(1):14-20 [PMID: 27798443]
  13. Front Microbiol. 2020 May 04;11:673 [PMID: 32431672]
  14. Foods. 2022 Dec 23;12(1): [PMID: 36613298]
  15. Front Microbiol. 2015 Apr 10;6:295 [PMID: 25914692]
  16. J Microbiol Methods. 2020 Sep;176:106009 [PMID: 32707152]
  17. Microorganisms. 2022 Oct 31;10(11): [PMID: 36363757]
  18. Front Physiol. 2017 Aug 03;8:543 [PMID: 28824443]
  19. Antibiotics (Basel). 2020 May 31;9(6): [PMID: 32486473]
  20. Front Public Health. 2014 Jul 31;2:103 [PMID: 25133139]
  21. J Microbiol Methods. 2006 Nov;67(2):310-20 [PMID: 16753236]
  22. Mol Microbiol. 2019 Jul;112(1):280-301 [PMID: 31070821]
  23. FEMS Microbiol Lett. 2014 Jul;356(1):8-19 [PMID: 24888326]
  24. Vet Microbiol. 2022 Mar;266:109341 [PMID: 35066418]
  25. Scand J Infect Dis. 2002;34(4):248-52 [PMID: 12064685]
  26. FEMS Microbiol Rev. 2010 Jul;34(4):415-25 [PMID: 20059548]
  27. Appl Microbiol Biotechnol. 2020 May;104(10):4281-4288 [PMID: 32215710]
  28. Front Microbiol. 2018 May 17;9:896 [PMID: 29867807]
  29. Front Microbiol. 2020 Jan 10;10:2920 [PMID: 31998253]
  30. J Appl Microbiol. 2002;92(3):433-42 [PMID: 11872118]
  31. Curr Microbiol. 2020 Apr;77(4):682-687 [PMID: 31811375]
  32. Compr Rev Food Sci Food Saf. 2020 Jan;19(1):149-183 [PMID: 33319518]
  33. Mar Life Sci Technol. 2020 May 13;3(2):189-203 [PMID: 37073345]
  34. Syst Appl Microbiol. 2021 May;44(3):126187 [PMID: 33677170]
  35. Appl Environ Microbiol. 2023 May 31;89(5):e0009623 [PMID: 37067418]
  36. J Clin Microbiol. 1983 Oct;18(4):986-7 [PMID: 6630476]
  37. J Med Microbiol. 2004 Jun;53(Pt 6):483-493 [PMID: 15150326]
  38. J Bacteriol. 2018 Sep 24;200(20): [PMID: 30082460]
  39. J Clin Microbiol. 2001 Oct;39(10):3684-9 [PMID: 11574591]
  40. Front Cell Infect Microbiol. 2018 Jul 24;8:243 [PMID: 30087857]
  41. Clin Microbiol Rev. 2015 Jul;28(3):687-720 [PMID: 26062576]

Word Cloud

Created with Highcharts 10.0.0VBNCstatecellsviablenonculturablePMAxx-qPCRenteredenvironmentalquantitativeanalysisATCCdayscellpresenceopportunisticbacterialpathogenlinkedrangehumandiseasesobjectivestudyinvestigatebacteriuminducemaintainedsterilizedphosphate-bufferedsaline4��CthreeweeksmonitoredusingpropidiummonoazidePMAxxcoupledreal-timePCRtargetingsubunitBgeneresultsdemonstrated5156215515619countsassessedconsistentlyremainedcloseinitiallevel10CFU���mlindicatingsubstantialportionpopulationNotablymorphologicalrevealedbecamecoccoidsignificantlysmallerresuscitatedtemperatureincreasehighlynutritiousgrowthmediumconclusionstressconvertedmayimportantsurvivalspreadformsconsideredclinicalmonitoringCharacterizationCampylobacterconcisusgenomospeciesresuscitation

Similar Articles

Cited By

No available data.